BBLG
Bone Biologics CorporationNASDAQHealthcare$1.24-3.23%ClosedMarket Cap: $2.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.26
P/S
0.00
EV/EBITDA
1.02
DCF Value
$4.21
FCF Yield
-124.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-59.5%
ROA
-53.6%
ROIC
-60.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-733.1K | $-684.6K | $-0.63 | — |
| FY 2025 | $0.00 | NaN% | $-3.2M | $-3.1M | $-2.65 | — |
| Q3 2025 | $0.00 | NaN% | $-715.3K | $-666.7K | $-0.37 | — |
| Q2 2025 | $0.00 | NaN% | $-748.1K | $-740.5K | $-1.33 | — |
| Q1 2025 | $0.00 | NaN% | $-1.0M | $-1.0M | $-0.32 | — |
| Q4 2024 | $0.00 | NaN% | $-1.6M | $-1.5M | $-0.48 | — |
| FY 2024 | $0.00 | NaN% | $-4.2M | $-4.1M | $-4.83 | — |
| Q3 2024 | $0.00 | NaN% | $-951.0K | $-941.0K | $-2.37 | — |
| Q2 2024 | $0.00 | NaN% | $-809.7K | $-783.7K | $-0.67 | — |
| Q1 2024 | $0.00 | NaN% | $-903.5K | $-866.0K | $-1.31 | — |
| Q4 2023 | $0.00 | NaN% | $-1.2M | $-1.6M | $48.03 | — |
| FY 2023 | $0.00 | NaN% | $-9.4M | $-8.9M | $-34.01 | — |